European Commission President Ursula von der Leyen’s silence about her dealings with drugmaker Pfizer leading to the EU’s biggest COVID-19 vaccine contract is hurting public trust and is a problem that will not go away, its ombudsman said.
https://www.pharmalive.com/wp-content/uploads/2023/03/ReutersEUombud3-1-2023.jpg7901080Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2023-03-01 07:13:152023-03-01 11:51:53EU silence over Pfizer COVID contract talks is problem that won't go away - watchdog
